171 related articles for article (PubMed ID: 24249635)
1. Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis.
Rius B; Titos E; Morán-Salvador E; López-Vicario C; García-Alonso V; González-Périz A; Arroyo V; Clària J
FASEB J; 2014 Feb; 28(2):836-48. PubMed ID: 24249635
[TBL] [Abstract][Full Text] [Related]
2. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
[TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats.
Zhao JS; Zhu FS; Liu S; Yang CQ; Chen XM
Chin Med J (Engl); 2012 Jul; 125(13):2316-21. PubMed ID: 22882855
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
8. Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice.
Li J; Deng X; Bai T; Wang S; Jiang Q; Xu K
Int Immunopharmacol; 2020 Nov; 88():106961. PubMed ID: 33182038
[TBL] [Abstract][Full Text] [Related]
9. Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.
López-Vicario C; González-Périz A; Rius B; Morán-Salvador E; García-Alonso V; Lozano JJ; Bataller R; Cofán M; Kang JX; Arroyo V; Clària J; Titos E
Gut; 2014 Feb; 63(2):344-55. PubMed ID: 23492103
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
11. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
12. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages.
Recchiuti A; Codagnone M; Pierdomenico AM; Rossi C; Mari VC; Cianci E; Simiele F; Gatta V; Romano M
FASEB J; 2014 Jul; 28(7):3090-102. PubMed ID: 24692596
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice.
Hellmann J; Tang Y; Kosuri M; Bhatnagar A; Spite M
FASEB J; 2011 Jul; 25(7):2399-407. PubMed ID: 21478260
[TBL] [Abstract][Full Text] [Related]
15. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
16. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.
Kang JW; Lee SM
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1025-1035. PubMed ID: 27317426
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
[TBL] [Abstract][Full Text] [Related]
19. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins.
González-Périz A; Horrillo R; Ferré N; Gronert K; Dong B; Morán-Salvador E; Titos E; Martínez-Clemente M; López-Parra M; Arroyo V; Clària J
FASEB J; 2009 Jun; 23(6):1946-57. PubMed ID: 19211925
[TBL] [Abstract][Full Text] [Related]
20. Positive effect of curcumin on inflammation and mitochondrial dysfunction in obese mice with liver steatosis.
Kuo JJ; Chang HH; Tsai TH; Lee TY
Int J Mol Med; 2012 Sep; 30(3):673-9. PubMed ID: 22751848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
